Assessment of Electromyographic Activity in the Quadriceps and Hamstrings of the Operated Limb Versus the Unaffected Limb in Patients Who Have Undergone ACL Surgery, With and Without Post-operative AMI - an Exploratory Study
AMIMYO
1 other identifier
interventional
40
1 country
1
Brief Summary
Traumatic injuries to the knee joint, such as an anterior cruciate ligament tear, can compromise the ability of the muscle at the front of your thigh-known as the quadriceps-to contract voluntarily, despite the anatomical integrity of the nerve and muscle structures responsible for contraction. This phenomenon, commonly known as 'arthrogenic motor inhibition' (AMI), is a major limiting factor for recovery and rehabilitation following an anterior cruciate ligament tear, as well as a potential cause of functional disability if left undiagnosed and untreated. Indeed, motor inhibition that persists during the early months of rehabilitation could lead to under-activation of the quadriceps and over-activation of the hamstrings (the muscles at the back of your thigh). It is of interest to assess, during the rehabilitation phase, the contraction capacity of the various quadriceps and hamstring muscles in the operated limb compared with the unaffected limb in patients who have undergone anterior cruciate ligament surgery and who experience post-operative motor inhibition, and in patients who have undergone anterior cruciate ligament surgery but do not experience post-operative motor inhibition. This is why this study has been initiated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 15, 2026
CompletedFirst Posted
Study publicly available on registry
June 22, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2027
Study Completion
Last participant's last visit for all outcomes
October 1, 2027
June 22, 2026
June 1, 2026
1.1 years
June 15, 2026
June 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
EMG activity
The average amplitude of EMG activity in the VM (Vastus Medialis) is assessed using the Root Mean Square (RMS) value, which is expressed in millivolts (mV). The RMS is recorded using surface electrodes placed on the vastus medialis. The primary outcome measure (activation deficit) is the absolute difference in RMS between the operated leg and the unaffected leg.
Month 3
Study Arms (1)
ACL Arm
EXPERIMENTALPatient with ACL rupture
Interventions
Surface EMG of the quadriceps (vastus medialis, vastus lateralis and vastus longus) and the semimembranosus and biceps femoris muscles of the hamstrings on both the affected and unaffected sides, to objectively assess quadriceps inhibition.
Eligibility Criteria
You may qualify if:
- Patient who has undergone ACL surgery at least 3 weeks ago
- Patient with no severe knee inflammation: stroke test ≤ 1+ and pain ≤ 3/10 (EN) at rest
- Patient with a Tegner score ≥ 5
- Patient with a Marx score ≥ 8
- Patient with or without a diagnosis of subjective AMI (Sonnery-Cottet et al. classification)
- French-speaking patients who do not object to the use of their data
You may not qualify if:
- Patient with a previous injury or surgery to the same or opposite knee
- Patient with a multi-ligament injury
- Patient with an AMI \> grade 2b (Sonnery-Cottet et al. classification)
- Patient with a BMI \> 30
- Pregnant or breastfeeding woman
- Patient with previous or current neurological and cardiovascular disorders or diseases
- Patient under legal protection: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Privé Jean Mermoz
Lyon, 69008, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 15, 2026
First Posted
June 22, 2026
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
October 1, 2027
Study Completion (Estimated)
October 1, 2027
Last Updated
June 22, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share